We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

30 hedge funds and large institutions have $123M invested in ProQR Therapeutics in 2014 Q3 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+30
Holders Change %
–
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
30
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$15.2M
2
RG
Redmile Group
California
+$12.3M
3
JHIU
Janus Henderson Investors US
Colorado
+$11.2M
4
Jennison Associates
Jennison Associates
New York
+$10.1M
5
BI
BVF Inc
California
+$8.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$16.3M +$15.2M +950,000 New
RG
2
Redmile Group
California
$12.1M +$12.3M +765,232 New
JHIU
3
Janus Henderson Investors US
Colorado
$12M +$11.2M +698,838 New
Jennison Associates
4
Jennison Associates
New York
$10.8M +$10.1M +630,370 New
BI
5
BVF Inc
California
$9.44M +$8.8M +549,000 New
DM
6
Deerfield Management
New York
$9.11M +$8.49M +530,000 New
BBA
7
Baker Bros. Advisors
New York
$6.88M +$6.41M +400,000 New
ClearBridge Investments
8
ClearBridge Investments
New York
$6.84M +$6.37M +397,786 New
Franklin Resources
9
Franklin Resources
California
$4.73M +$4.41M +275,000 New
HCMT
10
Highland Capital Management (Texas)
Texas
$4.11M +$3.83M +239,331 New
Federated Hermes
11
Federated Hermes
Pennsylvania
$3.48M +$3.24M +202,500 New
SFM
12
Sphera Funds Management
Israel
$3.44M +$3.2M +200,000 New
Millennium Management
13
Millennium Management
New York
$2.61M +$2.44M +152,001 New
Lord, Abbett & Co
14
Lord, Abbett & Co
New Jersey
$2.61M +$2.43M +151,844 New
VAM
15
Visium Asset Management
New York
$2.35M +$2.2M +137,016 New
Alyeska Investment Group
16
Alyeska Investment Group
Illinois
$2.33M +$2.17M +135,230 New
Marshall Wace
17
Marshall Wace
United Kingdom
$1.95M +$1.82M +113,676 New
Citadel Advisors
18
Citadel Advisors
Florida
$1.87M +$1.74M +108,715 New
Asset Management One
19
Asset Management One
Japan
$1.77M +$1.79M +111,613 New
LOAMU
20
Lombard Odier Asset Management (USA)
New York
$1.72M +$1.6M +100,000 New
PA
21
Perceptive Advisors
New York
$1.72M +$1.6M +100,000 New
Fidelity Investments
22
Fidelity Investments
Massachusetts
$1.25M +$1.16M +72,600 New
SAM
23
Sectoral Asset Management
Quebec, Canada
$1.2M +$1.12M +70,000 New
BA
24
BlackRock Advisors
Delaware
$1.04M +$974K +60,800 New
WMSA
25
Weiss Multi-Strategy Advisers
New York
$553K +$515K +32,160 New
1
2

PRQR Hedge Fund Activity: Q3 2014 in Review

30 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q3 2014, worth a combined $123M.

Buyers outnumbered sellers: 30 funds opened new PRQR positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $15.2M.

  • 30 institutional investors held ProQR Therapeutics (PRQR) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $123M of ProQR Therapeutics stock for Q3 2014.
  • 30 funds opened new ProQR Therapeutics positions in Q3 2014 and 0 closed out, a net change of +30 holders.
  • The largest ProQR Therapeutics buyer in Q3 2014 was OrbiMed, an estimated $15.2M added.

Based on aggregated 13F filings for Q3 2014.